AMA calls for more transparent prescription costs

11:57 EDT 15 Jun 2017 | Healio

In response to the recent spike of many prescription drug prices, the AMA adopted several policies to provide patients with more information about the drugs that they are prescribed and a rationale for price increases at its 2017 annual meeting, according to a press release. “Taken together, these policies would bring much needed transparency to drug pricing and provide a clear benefit to consumers struggling with exorbitant costs,” Barbara L. McAneny, MD, AMA President-elect, said in the release. “There seems to be no logic — or warning — to these price spikes. In the case of naloxone, communities are struggling to afford a life-saving treatment. Sunlight is needed to help respond to price shifts, because if the pricing trends continue, patients and communities will not be able to afford life-saving drugs.”

Original Article: AMA calls for more transparent prescription costs


More From BioPortfolio on "AMA calls for more transparent prescription costs"

Quick Search


Relevant Topics

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...